LEO Pharma A.S.

Industry / private company


Location: Ballerup, Denmark (DK) DK

ISNI: 0000000110107950

ROR: https://ror.org/05tzrdd39

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial (2025) Giménez-Arnau AM, Pinter A, Sondermann W, Reguiai Z, Woolf R, Lynde C, Legat FJ, et al. Journal article Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposure (2025) Schneider H, Bunick CG, Hillmann K, Huynh TN, Kempers S, Peschel N, Blume-Peytavi U, et al. Journal article Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase) (2021) Warren RB, Gold M, Gooderham M, Kircik LH, Lacour JP, Laws P, Liljedahl M, et al. Journal article Proactive Management with twice-a-week Use of topical Cal/BD Spray Foam Management extends the Effectiveness of the Treatment in Comparison to Reactive Management in Patients with Plaque Psoriasis (2021) Stein-Gold L, Alonso-Llamazares J, Laws P, Perrussel M, Yamauchi P, Thoning H, Toxvaerd C, Sticherling M Conference contribution A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE). (2021) Pinter A, Hoffmann M, Reich K, Augustin M, Kaplan K, Gudjonsdottir SD, Delvin T, Mrowietz U Journal article Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study (2019) Worm M, Bauer A, Elsner P, Mahler V, Molin S, Nielsen TSS Journal article Topical delgocitinib is an efficacious and well tolerated treatment for patients with chronic hand eczema (2019) Worm M, Bauer A, Elsner P, Mahler V, Molin S, Nielsen TSS Conference contribution